Reply to correspondence of Elst et al

Nithya Fernandopulle¹, Stephanie Zhang¹, Paul Soeding^{1

2}, Graham Mackay¹

Affiliations

¹ Department of Biochemistry and Pharmacology, The University of Melbourne, Melbourne, VIC, Australia.
² Department of Anaesthetics and Pain Management, Royal Melbourne Hospital, Parkville, VIC, Australia.

Comment

Nithya Fernandopulle et al. Clin Exp Allergy. 2021 Jul.

. 2021 Jul;51(7):978-979.

doi: 10.1111/cea.13844. Epub 2021 Mar 8.

Nithya Fernandopulle¹, Stephanie Zhang¹, Paul Soeding^{1

2}, Graham Mackay¹

¹ Department of Biochemistry and Pharmacology, The University of Melbourne, Melbourne, VIC, Australia.
² Department of Anaesthetics and Pain Management, Royal Melbourne Hospital, Parkville, VIC, Australia.

No abstract available

Comment on

MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex.
Fernandopulle NA, Zhang SS, Soeding PF, Mackay GA. Fernandopulle NA, et al. Clin Exp Allergy. 2021 May;51(5):685-695. doi: 10.1111/cea.13801. Epub 2020 Dec 20. Clin Exp Allergy. 2021. PMID: 33275825
MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by Sugammadex by Nithya A. Fernandopulle et al.
Elst J, Sabato V, Ebo DG. Elst J, et al. Clin Exp Allergy. 2021 Jul;51(7):976-977. doi: 10.1111/cea.13837. Epub 2021 Mar 8. Clin Exp Allergy. 2021. PMID: 33527585 No abstract available.

1. Fernandopulle NA, Zhang SS, Soeding PF, Mackay GA. MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex. Clin Exp Allergy. 2020;1-11. https://doi.org/10.1111/cea.13801. [Epub ahead of print]
1. Navines-Ferrer A, Serrano-Candelas E, Lafuente A, Munoz-Cano R, Martin M, Gastaminza G. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia. Sci Rep. 2018;8(1):1-11.
1. Ebo DG, Van der Poorten ML, Elst J, et al. Immunoglobulin E cross-linking or MRGPRX2 activation: clinical insights from rocuronium hypersensitivity. Br J Anaesth. 2021;126:e27-e29.
1. Van Gasse AL, Elst J, Bridts CH, et al. Rocuronium Hypersensitivity: Does Off-Target Occupation of the MRGPRX2 Receptor Play a Role? J Allergy Clin Immunol Pract. 2019;7:998-1003.
1. Alkanfari I, Gupta K, Jahan T, Ali H. Naturally occurring missense MRGPRX2 variants display loss of function phenotype for mast cell degranulation in response to substance P, hemokinin-1, human beta-defensin-3, and icatibant. J Immunol. 2018;201(2):343-349.